To ensure the quality and safety of medical services in primary healthcare institutions, China’s National Health Commission (NHC) and other relevant authorities issued a notice on 1 April 2026, outlining a three-year nationwide action.

Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

Qiagen said after the close of the market on Friday that it has reached a settlement with Becton Dickinson in a patent infringement lawsuit related to Qiagen's NeuMoDx 96 and NeuMoDx 288 clinical PCR systems.

Illumina reported after the close of the market on Thursday that its third quarter revenues grew 40 percent year over year.

Quidel reported after the close of the market on Thursday that its third quarter revenues rose 7 percent year over year.

As the 4th China International Import Expo (CIIE) was about to be launched, CACLP, one of the family members of GL events, and the unique medical expo on IVD industry, sincerely invites you to visit our booth with No. of 8.2A2-07!

On November 3, 2021, the Highest Science and Technology Award was given in Beijing, China.

OraSure Technologies reported after the close of the market on Wednesday that its third quarter revenues increased 12 percent year over year. Excluding COVID-19 product-related sales, revenues grew by 37 percent.

Qiagen reported after the close of the market on Wednesday that its third quarter revenues grew 11 percent year over year as growth in non-COVID-related product groups tempered an expected decline in COVID-19-related product sales.

Peng Yang, global vice president of Danaher and president of Danaher China, recently said in an exclusive interview with a reporter from 21st Century Business Herald during the J.P.Morgan Global Healthcare Conference, Shanghai Forum, "We believe China Will Become the World's Largest IVD Market ."

CTK Biotech said on Tuesday that its OnSite COVID-19 Ag Self Test has been CE marked.

Pacific Biosciences said after the close of the market on Tuesday that its third quarter revenues rose 83 percent, driven by growth in sequencing instruments and consumables.